INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction

M. R. Zile; M. R. R. Costanzo; E. M. Ippolito; Y. Zhang; R. Stapleton; A. Sadhu; J. Jimenez; J. Hobbs; V. Sharma; E. N. Warman; L. Streeter; J. Butler

doi:10.1002/ehf2.13231

$INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction$

Journal article

Open access

INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction

M. R. Zile, M. R. R. Costanzo, E. M. Ippolito, Y. Zhang, R. Stapleton, A. Sadhu, J. Jimenez, J. Hobbs, V. Sharma, E. N. Warman, …

ESC Heart Failure, Vol.8(2)

2021

DOI: https://doi.org/10.1002/ehf2.13231

Files and links (1)

url

https://doi.org/10.1002/ehf2.13231View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction
Creators: M. R. Zile - Medical University of South Carolina
M. R. R. Costanzo - Advocate Heart Institute
E. M. Ippolito - Medtronic
Y. Zhang - Medtronic
R. Stapleton - Baptist Medical Center Jacksonville
A. Sadhu
J. Jimenez
J. Hobbs - Medtronic
V. Sharma - Medtronic
E. N. Warman - Medtronic
L. Streeter - Medtronic
J. Butler - University of Mississippi Medical Center
Publication Details: ESC Heart Failure, Vol.8(2)
Identifiers: 991006036872202656
Academic Unit: Internal Medicine
Resource Type: Journal article